Cargando…
Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2
The coexistence of leucine-rich glioma-inactivated 1 (LGI1) and contactin-associated protein-like 2 (CASPR2) autoantibodies in the same individual is surprisingly often observed. We herein report the first case of LGI1 encephalitis followed by Isaacs syndrome in which LGI1 and CASPR2 antibodies in t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292997/ https://www.ncbi.nlm.nih.gov/pubmed/36223927 http://dx.doi.org/10.2169/internalmedicine.9670-22 |
_version_ | 1785062923928862720 |
---|---|
author | Murayama, Aki Sugaya, Keizo Hara, Makoto Kawazoe, Tomoya Tobisawa, Shinsuke Nakajima, Hideto Takahashi, Kazushi |
author_facet | Murayama, Aki Sugaya, Keizo Hara, Makoto Kawazoe, Tomoya Tobisawa, Shinsuke Nakajima, Hideto Takahashi, Kazushi |
author_sort | Murayama, Aki |
collection | PubMed |
description | The coexistence of leucine-rich glioma-inactivated 1 (LGI1) and contactin-associated protein-like 2 (CASPR2) autoantibodies in the same individual is surprisingly often observed. We herein report the first case of LGI1 encephalitis followed by Isaacs syndrome in which LGI1 and CASPR2 antibodies in the serum and cerebrospinal fluid (CSF) were measured during the entire disease course. After the resolution of limbic encephalitis, LGI1 antibodies disappeared from the CSF simultaneously with the appearance of CASPR2 antibodies in the serum. The alternating presence of these pathogenic autoantibodies along with the clinical and phenotypic alternations suggested that LGI1 encephalitis was associated with CASPR2 autoantibody production in the peripheral tissue, leading to CASPR2-associated Isaacs syndrome. |
format | Online Article Text |
id | pubmed-10292997 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-102929972023-06-28 Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2 Murayama, Aki Sugaya, Keizo Hara, Makoto Kawazoe, Tomoya Tobisawa, Shinsuke Nakajima, Hideto Takahashi, Kazushi Intern Med Case Report The coexistence of leucine-rich glioma-inactivated 1 (LGI1) and contactin-associated protein-like 2 (CASPR2) autoantibodies in the same individual is surprisingly often observed. We herein report the first case of LGI1 encephalitis followed by Isaacs syndrome in which LGI1 and CASPR2 antibodies in the serum and cerebrospinal fluid (CSF) were measured during the entire disease course. After the resolution of limbic encephalitis, LGI1 antibodies disappeared from the CSF simultaneously with the appearance of CASPR2 antibodies in the serum. The alternating presence of these pathogenic autoantibodies along with the clinical and phenotypic alternations suggested that LGI1 encephalitis was associated with CASPR2 autoantibody production in the peripheral tissue, leading to CASPR2-associated Isaacs syndrome. The Japanese Society of Internal Medicine 2022-10-12 2023-06-01 /pmc/articles/PMC10292997/ /pubmed/36223927 http://dx.doi.org/10.2169/internalmedicine.9670-22 Text en Copyright © 2023 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Murayama, Aki Sugaya, Keizo Hara, Makoto Kawazoe, Tomoya Tobisawa, Shinsuke Nakajima, Hideto Takahashi, Kazushi Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2 |
title | Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2 |
title_full | Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2 |
title_fullStr | Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2 |
title_full_unstemmed | Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2 |
title_short | Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2 |
title_sort | leucine-rich glioma-inactivated 1 encephalitis followed by isaacs syndrome: alternating presence of pathogenic autoantibodies to leucine-rich glioma-inactivated 1 and contactin-associated protein-like 2 |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292997/ https://www.ncbi.nlm.nih.gov/pubmed/36223927 http://dx.doi.org/10.2169/internalmedicine.9670-22 |
work_keys_str_mv | AT murayamaaki leucinerichgliomainactivated1encephalitisfollowedbyisaacssyndromealternatingpresenceofpathogenicautoantibodiestoleucinerichgliomainactivated1andcontactinassociatedproteinlike2 AT sugayakeizo leucinerichgliomainactivated1encephalitisfollowedbyisaacssyndromealternatingpresenceofpathogenicautoantibodiestoleucinerichgliomainactivated1andcontactinassociatedproteinlike2 AT haramakoto leucinerichgliomainactivated1encephalitisfollowedbyisaacssyndromealternatingpresenceofpathogenicautoantibodiestoleucinerichgliomainactivated1andcontactinassociatedproteinlike2 AT kawazoetomoya leucinerichgliomainactivated1encephalitisfollowedbyisaacssyndromealternatingpresenceofpathogenicautoantibodiestoleucinerichgliomainactivated1andcontactinassociatedproteinlike2 AT tobisawashinsuke leucinerichgliomainactivated1encephalitisfollowedbyisaacssyndromealternatingpresenceofpathogenicautoantibodiestoleucinerichgliomainactivated1andcontactinassociatedproteinlike2 AT nakajimahideto leucinerichgliomainactivated1encephalitisfollowedbyisaacssyndromealternatingpresenceofpathogenicautoantibodiestoleucinerichgliomainactivated1andcontactinassociatedproteinlike2 AT takahashikazushi leucinerichgliomainactivated1encephalitisfollowedbyisaacssyndromealternatingpresenceofpathogenicautoantibodiestoleucinerichgliomainactivated1andcontactinassociatedproteinlike2 |